FDA approves Abbott’s blood glucose monitoring device

(Reuters) – The U.S. Food and Drug Administration said it approved Abbott Laboratories’ glucose monitoring device for adults with diabetes, allowing millions of people to track their blood sugar levels without having to prick their fingers.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply